A Study of the Metabolic Syndrome in Patients With Systemic Lupus Erythematosus

Association of the Metabolic Syndrome and Systemic Lupus Erythematosus in Taiwan

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00982670

Enrollment

100

Registered

2009-09-23

Start date

2008-07-31

Completion date

2009-06-30

Last updated

2009-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Risk Factors, Metabolic Syndrome, Systemic Lupus Erythematosus

Keywords

Metabolic syndrome, Systemic lupus erythematosus

Brief summary

An increased prevalence of the metabolic syndrome has been found in patients with systemic lupus erythematosus in recent years.

Detailed description

This study will investigate the prevalence of the metabolic syndrome in patients with SLE in Taiwan. We expect our study will provide further understanding of the association between SLE and metabolic syndrome, which may give direction to prevent late cardiovascular morbidity and mortality in SLE patients.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Yes

Inclusion criteria

* Persons aged 18 and above. * Persons fulfill the diagnostic criteria of the 1997 American College of Rheumatology for systemic lupus erythematosus in the patient group.

Exclusion criteria

* Exclude a history myocardial infarction, angina or stroke.

Design outcomes

Primary

Measure	Time frame
The prevalence of the metabolic syndrome in patients with systemic lupus erythematosus in Taiwan	One year

Countries

Taiwan

Outcome results